MedTrace Logo

Use of PET-CT in the Management of Crohn's Disease

NCT01182467 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2015-04-10

No results posted yet for this study

Summary

Crohn's disease (CD) is an autoimmune disorder which affects over 700,000 people in the U.S. The disease can vary in severity and multiple drug classes are available to the disease depending on disease severity and complications. Our purpose will be to study how PET-CT scans can be used to better manage Crohn's Disease.

Conditions

Interventions

RADIATION

PET-CT scan

PET-CT scan performed at baseline to determine SUV-max

Sponsors & Collaborators

Principal Investigators

  • Arun Swaminath, MD · Columbia University

  • Masanori Ichise, MD · Columbia University

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01182467 on ClinicalTrials.gov